Quick Answer
Co-Diagnostics, Inc. reported Net Income of -$46.90 million for fiscal year 2025.
Co-Diagnostics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$46.90M | -24.6% |
| 2024 | -$37.64M | -6.5% |
| 2023 | -$35.33M | -148.2% |
| 2022 | -$14.24M | -138.8% |
| 2021 | $36.66M | -13.7% |
| 2020 | $42.48M | +785.6% |
| 2019 | -$6.20M | +1.2% |
| 2018 | -$6.27M | +9.9% |
| 2017 | -$6.96M | -260.8% |
| 2016 | -$1.93M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.89M | +39.3% | +23.8% |
| June 30, 2025 | -$7.73M | -1.7% | -2.6% |
| March 31, 2025 | -$7.53M | +19.1% | +22.3% |
| September 30, 2024 | -$9.70M | -62.1% | -27.6% |
| June 30, 2024 | -$7.60M | +14.8% | +18.4% |
| March 31, 2024 | -$9.31M | -61.8% | -55.7% |
| September 30, 2023 | -$5.98M | -339.5% | +32.9% |
| June 30, 2023 | -$8.92M | -232.0% | -55.0% |
- Co-Diagnostics, Inc. showed a decrease of -24.6% in Net Income compared to the prior fiscal year.
- Over the 2016–2025 period, Co-Diagnostics, Inc.’s net income has declined by 2331.5% (from -$1.93 million to -$46.90 million).
- The most recent figure is from Co-Diagnostics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: